Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Sacituzumab Govitecan in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
VB-111 in Surgically Accessible Recurrent/Progressive GBM
- Status
- TERMINATED
- Phase
- PHASE2
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
- Status
- RECRUITING
- Phase
- PHASE1
Individual Patient Compassionate Use of GX-I7
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)
- Status
- RECRUITING
- Phase
- PHASE2
Niraparib/TTFields in GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1